301301.SZ
川宁生物
SZSE · C 制造业 · CN
CNY 8.62
−4.43%Margins
Gross margin
25.5%
EBITDA margin
34.7%
EBIT margin
16.9%
Net margin
13.4%
FCF margin
11.6%
7.2%
Return on equity
5.7%
Return on assets
7.9%
Return on invested capital
0.42x
Asset turnover
CNY 615.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026